Skip to content

13F-HR filed by Ghost Tree Capital, LLC

Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2015-12-31, filed 2016-02-16, with 47 holding rows worth $244,231,000.

Accession
0001387131-16-004252
Filed
2016-02-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2015

A holdings report, 47 entries on the cover page, a total value of $244,231,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $244,231,000 with VALUE read as thousands by filing date, 13F file number 028-16059. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NUVASIVE INC670704105COM230,000$12,445,000thousands by filing date
Amgen Inc.031162100COM75,000$12,175,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS500,000$12,090,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock230,000$11,834,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM200,000$11,660,000thousands by filing date
SEATTLE GENETICS INC812578102COM225,000$10,098,000thousands by filing date
Mallinckrodt PlcG5785G107SHS135,000$10,075,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock750,000$9,848,000thousands by filing date
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock250,000$8,913,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW120,000$8,134,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM250,000$7,900,000thousands by filing date
ZELTIQ AESTHETICS INC98933Q108COM275,000$7,846,000thousands by filing date
BLUEBIRD BIO INC09609G100COM120,000$7,706,000thousands by filing date
BIOGEN INC COM09062X103Stock25,000$7,659,000thousands by filing date
SPECTRANETICS CORP84760C107COM435,000$6,551,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM600,000$6,474,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock90,000$6,130,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM400,000$5,884,000thousands by filing date
NEVRO CORP64157F103COM85,000$5,738,000thousands by filing date
INCYTE CORP COM45337C102Stock50,000$5,423,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR80,000$5,314,000thousands by filing date
VITAE PHARMACEUTICALS INC92847N103COM275,000$4,978,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM100,000$4,278,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock45,000$4,236,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock100,000$4,150,000thousands by filing date
Tandem Diabetes Care, Inc.875372104COM350,000$4,134,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM100,000$3,858,000thousands by filing date
RETROPHIN INC761299106COM200,000$3,858,000thousands by filing date
SYNERGY PHARMACEUTICALS DEL871639308COM NEW600,000$3,402,000thousands by filing date
GENMARK DIAGNOSTICS INC372309104COM410,000$3,182,000thousands by filing date
Alcobra LtdM2239P109SHS500,000$3,140,000thousands by filing date
TONIX PHARMACEUTICALS HOLDING890260201COM NEW350,000$2,685,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR210,000$2,533,000thousands by filing date
ENTELLUS MED INC29363K105COM150,000$2,529,000thousands by filing date
VERACYTE INC COM92337F107Stock350,000$2,520,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y859COM PAR NO PAR151,630$2,318,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock30,000$2,304,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM50,000$1,750,000thousands by filing datecall
STANDARD BIOTOOLS INC34385P108COM150,000$1,622,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW55,000$1,329,000thousands by filing date
CORIUM INTL INC21887L107COM125,000$1,015,000thousands by filing date
REGENXBIO INC75901B107COM60,000$996,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM100,000$970,000thousands by filing datecall
CATALYST PHARMACEUTICALS INC14888U101COM376,000$921,000thousands by filing date
AKARI THERAPEUTICS PLC00972G108ADR47,116$683,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD72,726$553,000thousands by filing date
OCERA THERAPEUTICS INC COM67552A108COM125,000$390,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001387131-16-004252this filing2016-02-16acceptance time not in the bulk data set
13F-HR/A 0001387131-16-004295 base2016-02-17acceptance time not in the bulk data set